Citius Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Citius Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2010 to Q2 2024.
  • Citius Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$10.6M, a 22.6% decline year-over-year.
  • Citius Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$41.1M, a 20.2% decline year-over-year.
  • Citius Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$36.7M, a 10.3% decline from 2022.
  • Citius Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$33.3M, a 41.6% decline from 2021.
  • Citius Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$23.5M, a 32.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$41.1M -$10.6M -$1.96M -22.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$39.1M -$11M -$285K -2.67% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$38.8M -$9.34M -$2.09M -28.8% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 -$36.7M -$10.1M -$2.58M -34.1% Jul 1, 2023 Sep 30, 2023 10-K 2023-12-29
Q2 2023 -$34.2M -$8.67M +$245K +2.74% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$34.4M -$10.7M -$3.09M -40.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$31.3M -$7.25M +$2.01M +21.7% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 -$33.3M -$7.55M -$2.35M -45.1% Jul 1, 2022 Sep 30, 2022 10-K 2023-12-29
Q2 2022 -$31M -$8.92M -$2.93M -49% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$28M -$7.59M -$3.4M -81.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$24.6M -$9.26M -$1.1M -13.5% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q3 2021 -$23.5M -$5.2M -$1.06M -25.7% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-22
Q2 2021 -$22.5M -$5.98M -$1.3M -27.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$21.2M -$4.19M +$245K +5.53% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$21.4M -$8.16M -$3.71M -83.4% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q3 2020 -$17.7M -$4.14M -$484K -13.2% Jul 1, 2020 Sep 30, 2020 10-K 2021-12-15
Q2 2020 -$17.2M -$4.69M -$262K -5.92% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$17M -$4.43M -$791K -21.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$16.2M -$4.45M -$575K -14.9% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 -$15.6M -$3.66M +$4.22K +0.12% Jul 1, 2019 Sep 30, 2019 10-K 2020-12-16
Q2 2019 -$15.6M -$4.43M -$2.41M -119% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$13.2M -$3.64M +$1.22M +25.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$14.4M -$3.87M -$630K -19.4% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-13
Q3 2018 -$13.8M -$3.66M -$1.26M -52.4% Jul 1, 2018 Sep 30, 2018 10-K 2019-12-16
Q2 2018 -$12.5M -$2.02M +$237K +10.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$12.8M -$4.87M -$2.32M -91.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$10.4M -$3.24M -$458K -16.4% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$9.99M -$2.4M +$1M +29.5% Jul 1, 2017 Sep 30, 2017 10-K 2019-12-16
Q2 2017 -$11M -$2.26M -$129K -6.06% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$10.9M -$2.54M -$1.87M -279% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$8.99M -$2.78M -$1.54M -124% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
Q3 2016 -$7.45M -$3.41M -$2.44M -252% Jul 1, 2016 Sep 30, 2016 10-K 2018-12-11
Q2 2016 -$5.01M -$2.13M -$1.35M -175% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$3.66M -$672K -$62.7K -10.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$3.6M -$1.24M -$366K -41.6% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 -$3.23M -$968K -$865K -836% Jul 1, 2015 Sep 30, 2015 10-K 2017-12-13
Q2 2015 -$2.37M -$774K -$772K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$1.59M -$609K -$559K -1122% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-20
Q4 2014 -$1.03M -$879K -$380K -76.1% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-12
Q3 2014 -$654K -$103K Jul 1, 2014 Sep 30, 2014 10-K 2016-12-23
Q2 2014 -$1.31K* +$3.43M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$49.8K -$40.5K -434% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$499K -$499K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q2 2013 -$3.44M -$3.43M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$9.34K -$2.64K -39.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$636* +$1.56K Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-19
Q2 2012 -$17.5K -$6.18K* +$914 Apr 1, 2012 Jun 30, 2012 10-Q 2013-09-18
Q1 2012 -$18.4K -$6.7K +$407 +5.73% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q4 2011 -$18.8K -$2.2K* +$6.8K Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-08
Q3 2011 -$25.6K -$2.44K Jul 1, 2011 Sep 30, 2011 10-K 2013-01-15
Q2 2011 -$7.1K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-17
Q1 2011 -$7.11K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q4 2010 -$9K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.